EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluconazole worsened lung inflammation, partly through lung microbiome dysbiosis in mice with ovalbumin-induced asthma

Jesadakorn Worasilchai, Piyapat Thongchaichayakon, Kittipat Chansri, Supichaya Leelahavanichkul, Vathin Chiewvit, Peerapat Visitchanakun, Poorichaya Somparn, Pratsanee Hiengrach

PeerJ · 2024

DOI: 10.7717/peerj.18421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Jesadakorn Worasilchai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence on Translational Research in Inflammation and Immunology (CETRII), Department of Microbiology, Faculty of Medicine, Chulalongkor…. Hauptthemen laut MEDLINE: Asthma, Fluconazole, Mice, Inbred C57BL, Ovalbumin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research and Diagnostic Center for Emerging Infectious Diseases, Faculty of Medicine, Khon Kaen University and Mycology laboratory, Department of microbiology, Faculty of Medicine, Chulalongkorn University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Innate immunity in asthma may be influenced by alterations in lung microbiota, potentially affecting disease severity. This study investigates the differences in lung inflammation and microbiome between asthma-ovalbumin (OVA) administered with and without fluconazole treatment in C57BL/6 mice. Additionally, the role of inflammation was examined in an in vitro study using a pulmonary cell line. At 30 days post-OVA administration, allergic asthma mice exhibited increased levels of IgE and IL-4 in serum and lung tissue, higher pathological scores, and elevated eosinophils in bronchoalveolar lavage fluid (BALF) compared to control mice. Asthma inflammation was characterized by elevated serum IL-6, increased lung cytokines (TNF-α, IL-6, IL-10), and higher fungal abundance confirmed by polymerase chain reaction (PCR). Fluconazole-treated asthma mice displayed higher levels of cytokines in serum and lung tissue (TNF-α and IL-6), increased pathological scores, and a higher number of mononuclear cells in BALF, with undetectable fungal levels compared to untreated mice. Lung microbiome analysis revealed similarities between control and asthma mice; however, fluconazole-treated asthma mice exhibited higher Bacteroidota levels, lower Firmicutes, and reduced bacterial abundance. Pro-inflammatory cytokine production was increased in supernatants of the pulmonary cell line (NCI-H292) after co-stimulation with LPS and beta-glucan (BG) compared to LPS alone. Fluconazole treatment in OVA-induced asthma mice exacerbated inflammation, partially due to fungi and Gram-negative bacteria, as demonstrated by LPS+BG-activated pulmonary cells. Therefore, fluconazole should be reserved for treating fungal asthma rather than asthma caused by other etiologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaFluconazoleMice, Inbred C57BLOvalbuminDysbiosisLungBronchoalveolar Lavage FluidMicrobiotaAnimalsMiceCytokinesPneumoniaFemaleDisease Models, AnimalImmunoglobulin EAntifungal Agents

Stichwörter der Autor:innen

AsthmaFungiMicrobiomeOvalbumin

Substanzen

FluconazoleOvalbuminCytokinesImmunoglobulin EAntifungal Agents

Autor:innen und Institutionen

  • Center of Excellence on Translational Research in Inflammation and Immunology (CETRII), Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Center of Excellence in Systems Biology, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Research and Diagnostic Center for Emerging Infectious Diseases (RCEID), Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Förderung

  • Research and Diagnostic Center for Emerging Infectious Diseases
  • Faculty of Medicine, Khon Kaen University and Mycology laboratory
  • Department of microbiology, Faculty of Medicine, Chulalongkorn University

Zitieren

APA

Worasilchai, J., Thongchaichayakon, P., Chansri, K., Leelahavanichkul, S., Chiewvit, V., Visitchanakun, P., Somparn, P., & Hiengrach, P. (2024). Fluconazole worsened lung inflammation, partly through lung microbiome dysbiosis in mice with ovalbumin-induced asthma. PeerJ. https://doi.org/10.7717/peerj.18421

Vancouver

Worasilchai J, Thongchaichayakon P, Chansri K, Leelahavanichkul S, Chiewvit V, Visitchanakun P, et al. Fluconazole worsened lung inflammation, partly through lung microbiome dysbiosis in mice with ovalbumin-induced asthma. PeerJ. 2024. doi:10.7717/peerj.18421

BibTeX
@article{Worasilchai2024,
  author = {Worasilchai, Jesadakorn and Thongchaichayakon, Piyapat and Chansri, Kittipat and Leelahavanichkul, Supichaya and Chiewvit, Vathin and Visitchanakun, Peerapat and Somparn, Poorichaya and Hiengrach, Pratsanee},
  title = {Fluconazole worsened lung inflammation, partly through lung microbiome dysbiosis in mice with ovalbumin-induced asthma},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.18421}
}
Kostenlos starten →